Literature DB >> 17255291

Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference.

Michael B Atkins1, Marc S Ernstoff, Robert A Figlin, Keith T Flaherty, Daniel J George, William G Kaelin, Eugene D Kwon, Towia A Libermann, W Marston Linehan, David F McDermott, Augusto C Ochoa, Allan J Pantuck, Brian I Rini, Mark A Rosen, Jeffrey A Sosman, Vikas P Sukhatme, Johannes W Vieweg, Christopher G Wood, Laura King.   

Abstract

Innovations and Challenges in Renal Cancer, chaired by Michael B. Atkins, was held April 28 to 29, 2006 in Cambridge, Massachusetts. The conference brought together leading experts in the fields of cancer research, medical oncology, urology, immunology, radiology, and immunotherapy, with the goal of advancing the field of renal cancer treatment by critiquing new data from ongoing clinical trials and stimulating communication among those involved in basic and clinical research. The conference proceedings published in this educational supplement to Clinical Cancer Research are intended to provide timely information and recommendations on important aspects of renal cancer genetics and biology and advances in prognostic classification and treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255291     DOI: 10.1158/1078-0432.CCR-06-2231

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  16 in total

Review 1.  RLIP76 Targeted Therapy for Kidney Cancer.

Authors:  Sharad S Singhal; Jyotsana Singhal; James Figarola; David Horne; Sanjay Awasthi
Journal:  Pharm Res       Date:  2015-05-29       Impact factor: 4.200

2.  2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma.

Authors:  Lokesh Dalasanur Nagaprashantha; Rit Vatsyayan; Jyotsana Singhal; Poorna Lelsani; Laszlo Prokai; Sanjay Awasthi; Sharad S Singhal
Journal:  Carcinogenesis       Date:  2011-02-08       Impact factor: 4.944

3.  Automated noninvasive classification of renal cancer on multiphase CT.

Authors:  Marius George Linguraru; Shijun Wang; Furhawn Shah; Rabindra Gautam; James Peterson; W Marston Linehan; Ronald M Summers
Journal:  Med Phys       Date:  2011-10       Impact factor: 4.071

4.  Renal Tumor Quantification and Classification in Contrast-Enhanced Abdominal CT.

Authors:  Marius George Linguraru; Jianhua Yao; Rabindra Gautam; James Peterson; Zhixi Li; W Marston Linehan; Ronald M Summers
Journal:  Pattern Recognit       Date:  2009-06-01       Impact factor: 7.740

Review 5.  Chemokines as therapeutic targets in renal cell carcinoma.

Authors:  Karen L Reckamp; Robert M Strieter; Robert A Figlin
Journal:  Expert Rev Anticancer Ther       Date:  2008-06       Impact factor: 4.512

6.  Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma.

Authors:  Alexander S Parker; Christine M Lohse; Bradley C Leibovich; John C Cheville; Yuri M Sheinin; Eugene D Kwon
Journal:  Hum Pathol       Date:  2008-06-05       Impact factor: 3.466

7.  PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.

Authors:  Brenda L Petrella; Constance E Brinckerhoff
Journal:  Cancer Biol Ther       Date:  2009-07-30       Impact factor: 4.742

8.  Establishment of a bioluminescent Renca cell line for renal carcinoma research.

Authors:  Jie Ding; Chao Wang; Xiaofeng Chang
Journal:  Int Urol Nephrol       Date:  2017-10-03       Impact factor: 2.370

9.  Englerin A, a selective inhibitor of renal cancer cell growth, from Phyllanthus engleri.

Authors:  Ranjala Ratnayake; David Covell; Tanya T Ransom; Kirk R Gustafson; John A Beutler
Journal:  Org Lett       Date:  2009-01-01       Impact factor: 6.005

Review 10.  Tissue-based research in kidney cancer: current challenges and future directions.

Authors:  Sabina Signoretti; Gennady Bratslavsky; Frederick M Waldman; Victor E Reuter; John Haaga; Maria Merino; George V Thomas; Michael R Pins; Towia Libermann; John Gillespie; Joseph E Tomaszewski; Carolyn C Compton; Andrew Hruszkewycz; W Marston Linehan; Michael B Atkins
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.